New drug trial aims to tame deadly lung condition
Disease control
Recruiting now
This study tests a new medicine called GEn-1124 in 52 adults with acute respiratory distress syndrome (ARDS), a severe lung injury that makes breathing very difficult. Participants receive the drug through an IV twice daily for 5 days, starting as soon as possible after diagnosis…
Phase: PHASE2 • Sponsor: GEn1E Lifesciences • Aim: Disease control
Last updated May 11, 2026 20:53 UTC